Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253589 | SCV000313599 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000253589 | SCV000538283 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 86/13006=0.6% |
Mendelics | RCV000988051 | SCV001137611 | likely benign | Hereditary spherocytosis type 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000988051 | SCV001159527 | benign | Hereditary spherocytosis type 1 | 2024-10-02 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001508609 | SCV001714874 | uncertain significance | not provided | 2023-05-17 | criteria provided, single submitter | clinical testing | BS1, BP4, BP7 |
Ce |
RCV001508609 | SCV004010777 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | ANK1: BS2 |